Tiered Pharmacy Copayments for Medications Update, 8153-8154 [2018-03724]
Download as PDF
<![CDATA[
Federal Register / Vol. 83, No. 37 / Friday, February 23, 2018 / Notices
stress-testing information across
institutions. The change also would
ensure that future collections of this
information remain uniform across the
agencies.
With OMB approval, the first annual
filing deadline for the FFIEC 016 report
form would be July 31, 2018, using
information as of December 31, 2017.
II. Request for Comment
Public comment is requested on all
aspects of this joint notice. Comments
are specifically invited on:
(a) Whether the collections of
information that are the subject of this
notice are necessary for the proper
performance of the agencies’ functions,
including whether the information has
practical utility;
(b) The accuracy of the agencies’
estimates of the burden of the
information collections as they are
proposed to be revised, including the
validity of the methodology and
assumptions used;
(c) Ways to enhance the quality,
utility, and clarity of the information to
be collected;
(d) Ways to minimize the burden of
information collections on respondents,
including through the use of automated
collection techniques or other forms of
information technology; and
(e) Estimates of capital or start-up
costs and costs of operation,
maintenance, and purchase of services
to provide the information.
Comments submitted in response to
the joint notice will be shared among
the agencies. All comments will become
a matter of public record.
Dated: February 15, 2018.
Karen Solomon,
Acting Senior Deputy Comptroller and Chief
Counsel, Office of the Comptroller of the
Currency.
Board of Governors of the Federal Reserve
System, February 12, 2018.
Ann E. Misback,
Secretary of the Board.
Dated at Washington, DC, on February 12,
2018.
Federal Deposit Insurance Corporation.
Robert E. Feldman,
Executive Secretary.
[FR Doc. 2018–03736 Filed 2–22–18; 8:45 am]
BILLING CODE 4810–33–P; 6210–01–P; 6714–01–P
DEPARTMENT OF VETERANS
AFFAIRS
Tiered Pharmacy Copayments for
Medications Update
Department of Veterans Affairs.
Notice.
AGENCY:
ACTION:
This Department of Veterans
Affairs (VA) notice updates the
information on Tier 1 medications.
FOR FURTHER INFORMATION CONTACT:
Joseph Duran, Office of Community
Care (10D), Veterans Health
Administration (VHA), Department of
Veterans Affairs, 810 Vermont Avenue
NW, Washington, DC 20420,
Joseph.Duran2@va.gov, (303) 372–4629
(this is not a toll free number).
SUPPLEMENTARY INFORMATION: Section
17.110 of Title 38, Code of Federal
Regulations, governs copayments for
medications that VA provides to
SUMMARY:
veterans. Section 17.110 provides the
methodologies for establishing the
copayment amount for each 30-day or
less supply of medication provided by
VA on an outpatient basis (other than
medication administered during
treatment). ‘‘Tier 1 medication means a
multi-source medication that has been
identified using the process described in
paragraph (b)(2) of this section.’’
Section 17.110 provides that a list of
Tier 1 medications will either be
published as a notice in the Federal
Register or will be posted on VA’s
website at www.va.gov/health at least
once per year.
Based on the methodologies set forth
in § 17.110, this notice updates the list
of Tier 1 medications. Not less than
once per year, VA will identify a subset
of multi-source medications as Tier 1
medications. Only medications that
meet all of the criteria in paragraphs
(b)(2)(i), (ii), and (iii) will be eligible to
be considered Tier 1 medications, and
only those medications that meet all of
the criteria in paragraph (b)(2)(i) of this
section will be assessed using the
criteria in paragraphs (b)(2)(ii) and (iii).
As of the date of this notice, the Tier 1
medication list at individual VA
medical facilities based on the
methodologies in § 17.110 will be
posted on VA’s website at www.va.gov/
health under the heading ‘‘Tier 1 Copay
Medication List.’’
The following table is the Tier 1
Copay Medication List that is effective
January 1, 2018, and will remain in
effect until December 31, 2018.
Condition
VA product name
Arthritis & Pain ..............................................................................................................................
Blood Thinners & Platelet Inhibitors. ............................................................................................
daltland on DSKBBV9HB2PROD with NOTICES
Bone Health ..................................................................................................................................
Cholesterol ....................................................................................................................................
Dementia .......................................................................................................................................
Diabetes ........................................................................................................................................
Electrolyte Supplement .................................................................................................................
Gastrointestinal Health ..................................................................................................................
VerDate Sep<11>2014
18:52 Feb 22, 2018
Jkt 244001
PO 00000
Frm 00109
Fmt 4703
Sfmt 4703
8153
Aspirin buffered tablet.
Aspirin chewable tablet.
Aspirin enteric coated tablet.
Allopurinol tablet.
Diclofenac Sodium EC tablet.
Ibuprofen tablet.
Meloxicam tablet.
Naproxen tablet.
Clopidogrel Bisulfate tablet.
Warfarin Sodium tablet.
Alendronate tablet.
Atorvastatin tablet.
Gemfibrozil tablet.
Lovastatin tablet.
Niacin (Slo-Niacin) tablet.
Pravastatin tablet.
Simvastatin tablet.
Donepezil tablet.
Glipizide tablet.
Metformin HCL tablet.
Metformin HCL 24hr (SA) tablet.
Potassium SA tablet.
Potassium SA Dispersible tablet.
Omeprazole EC capsule.
Pantoprazole Sodium EC capsule.
Ranitidine tablet.
E:\FR\FM\23FEN1.SGM
23FEN1
8154
Federal Register / Vol. 83, No. 37 / Friday, February 23, 2018 / Notices
Condition
VA product name
Glaucoma & Eye Care ..................................................................................................................
Heart Health & Blood Pressure ....................................................................................................
Mental Health ................................................................................................................................
Parkinson Diseases/Restless Legs Syndrome .............................................................................
Seizures ........................................................................................................................................
Thyroid Conditions ........................................................................................................................
Urologic (Bladder & Prostate) Health. ..........................................................................................
daltland on DSKBBV9HB2PROD with NOTICES
Signing Authority
The Secretary of Veterans Affairs, or
designee, approved this document and
authorized the undersigned to sign and
submit the document to the Office of the
Federal Register for publication
electronically as an official document of
the Department of Veterans Affairs. Gina
S. Farrisee, Deputy Chief of Staff,
VerDate Sep<11>2014
18:52 Feb 22, 2018
Jkt 244001
Department of Veterans Affairs,
approved this document on February
12, 2018, for publication.
PO 00000
Brimonidine 0.2% solution.
Dorzolamide 2%/Timolol 0.5% sol.
Latanoprost 0.005% solution.
Amlodipine tablet.
Aspirin (see Arthritis & Pain).
Atenolol tablet.
Carvedilol tablet.
Chlorthalidone tablet.
Clonidine tablet.
Digoxin tablet.
Diltiazem 24HR capsule.
Diltiazem HCL tablet.
Enalapril Maleate tablet.
Furosemide tablet.
Hydralazine HCL tablet.
Hydrochlorothiazide tablet/capsule.
Hydrochlorothiazide/Lisinopril tablet.
Hydrochlorothiazide/Triamterene cap/tab.
Isosorbide Mononitrate SA tablet.
Lisinopril tablet.
Losartan tablet.
Metoprolol Succinate SA tablet.
Metoprolol Tartrate tablet.
Nifedipine SA capsule.
Nitroglycerin sublingual tablet.
Prazosin HCL capsule.
Propranolol HCL tablet.
Spironolactone tablet.
Valsartan tablet.
Verapamil HCL tablet.
Verapamil HCL SA tablet.
Bupropion HCL tablet.
Bupropion HCL SA (12HR–SR) tablet.
Bupropion HCL SA (24HR–XL) tablet.
Buspirone HCL tablet.
Citalopram Hydrobromide tablet.
Duloxetine HCL EC capsule.
Escitalopram Oxalate tablet.
Fluoxetine capsule/tablets.
Mirtazapine tablet.
Paroxetine HCL tablet.
Quetiapine Fumarate tablet.
Risperidone tablet.
Risperidone tablet, disintegrating.
Sertraline HCL tablet.
Trazodone tablet.
Venlafaxine HCL tablet.
Venlafaxine HCL SA tablet/cap.
Carbidopa/Levodopa tablet.
Gabapentin capsule.
Lamotrigine tablet.
Topiramate tablet.
Levothyroxine Sodium tablet.
Alfuzosin HCL SA tablet.
Doxazosin Mesylate tablet.
Finasteride tablet.
Oxybutynin Chloride tablet.
Oxybutynin Chloride SA tablet.
Tamsulosin HCL capsule.
Terazosin HCL capsule.
Dated: February 12, 2018.
Jeffrey Martin,
Impact Analyst, Office of Regulation Policy
& Management, Office of the Secretary,
Department of Veterans Affairs.
[FR Doc. 2018–03724 Filed 2–22–18; 8:45 am]
BILLING CODE 8320–01–P
Frm 00110
Fmt 4703
Sfmt 9990
E:\FR\FM\23FEN1.SGM
23FEN1
]]>Agencies
[Federal Register Volume 83, Number 37 (Friday, February 23, 2018)]
[Notices]
[Pages 8153-8154]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-03724]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF VETERANS AFFAIRS
Tiered Pharmacy Copayments for Medications Update
AGENCY: Department of Veterans Affairs.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This Department of Veterans Affairs (VA) notice updates the
information on Tier 1 medications.
FOR FURTHER INFORMATION CONTACT: Joseph Duran, Office of Community Care
(10D), Veterans Health Administration (VHA), Department of Veterans
Affairs, 810 Vermont Avenue NW, Washington, DC 20420,
[email protected], (303) 372-4629 (this is not a toll free number).
SUPPLEMENTARY INFORMATION: Section 17.110 of Title 38, Code of Federal
Regulations, governs copayments for medications that VA provides to
veterans. Section 17.110 provides the methodologies for establishing
the copayment amount for each 30-day or less supply of medication
provided by VA on an outpatient basis (other than medication
administered during treatment). ``Tier 1 medication means a multi-
source medication that has been identified using the process described
in paragraph (b)(2) of this section.''
Section 17.110 provides that a list of Tier 1 medications will
either be published as a notice in the Federal Register or will be
posted on VA's website at www.va.gov/health at least once per year.
Based on the methodologies set forth in Sec. 17.110, this notice
updates the list of Tier 1 medications. Not less than once per year, VA
will identify a subset of multi-source medications as Tier 1
medications. Only medications that meet all of the criteria in
paragraphs (b)(2)(i), (ii), and (iii) will be eligible to be considered
Tier 1 medications, and only those medications that meet all of the
criteria in paragraph (b)(2)(i) of this section will be assessed using
the criteria in paragraphs (b)(2)(ii) and (iii). As of the date of this
notice, the Tier 1 medication list at individual VA medical facilities
based on the methodologies in Sec. 17.110 will be posted on VA's
website at www.va.gov/health under the heading ``Tier 1 Copay
Medication List.''
The following table is the Tier 1 Copay Medication List that is
effective January 1, 2018, and will remain in effect until December 31,
2018.
----------------------------------------------------------------------------------------------------------------
Condition VA product name
----------------------------------------------------------------------------------------------------------------
Arthritis & Pain........................ Aspirin buffered tablet.
Aspirin chewable tablet.
Aspirin enteric coated tablet.
Allopurinol tablet.
Diclofenac Sodium EC tablet.
Ibuprofen tablet.
Meloxicam tablet.
Naproxen tablet.
Blood Thinners & Platelet Inhibitors.... Clopidogrel Bisulfate tablet.
Warfarin Sodium tablet.
Bone Health............................. Alendronate tablet.
Cholesterol............................. Atorvastatin tablet.
Gemfibrozil tablet.
Lovastatin tablet.
Niacin (Slo-Niacin) tablet.
Pravastatin tablet.
Simvastatin tablet.
Dementia................................ Donepezil tablet.
Diabetes................................ Glipizide tablet.
Metformin HCL tablet.
Metformin HCL 24hr (SA) tablet.
Electrolyte Supplement.................. Potassium SA tablet.
Potassium SA Dispersible tablet.
Gastrointestinal Health................. Omeprazole EC capsule.
Pantoprazole Sodium EC capsule.
Ranitidine tablet.
[[Page 8154]]
Glaucoma & Eye Care..................... Brimonidine 0.2% solution.
Dorzolamide 2%/Timolol 0.5% sol.
Latanoprost 0.005% solution.
Heart Health & Blood Pressure........... Amlodipine tablet.
Aspirin (see Arthritis & Pain).
Atenolol tablet.
Carvedilol tablet.
Chlorthalidone tablet.
Clonidine tablet.
Digoxin tablet.
Diltiazem 24HR capsule.
Diltiazem HCL tablet.
Enalapril Maleate tablet.
Furosemide tablet.
Hydralazine HCL tablet.
Hydrochlorothiazide tablet/capsule.
Hydrochlorothiazide/Lisinopril tablet.
Hydrochlorothiazide/Triamterene cap/tab.
Isosorbide Mononitrate SA tablet.
Lisinopril tablet.
Losartan tablet.
Metoprolol Succinate SA tablet.
Metoprolol Tartrate tablet.
Nifedipine SA capsule.
Nitroglycerin sublingual tablet.
Prazosin HCL capsule.
Propranolol HCL tablet.
Spironolactone tablet.
Valsartan tablet.
Verapamil HCL tablet.
Verapamil HCL SA tablet.
Mental Health........................... Bupropion HCL tablet.
Bupropion HCL SA (12HR-SR) tablet.
Bupropion HCL SA (24HR-XL) tablet.
Buspirone HCL tablet.
Citalopram Hydrobromide tablet.
Duloxetine HCL EC capsule.
Escitalopram Oxalate tablet.
Fluoxetine capsule/tablets.
Mirtazapine tablet.
Paroxetine HCL tablet.
Quetiapine Fumarate tablet.
Risperidone tablet.
Risperidone tablet, disintegrating.
Sertraline HCL tablet.
Trazodone tablet.
Venlafaxine HCL tablet.
Venlafaxine HCL SA tablet/cap.
Parkinson Diseases/Restless Legs Carbidopa/Levodopa tablet.
Syndrome.
Seizures................................ Gabapentin capsule.
Lamotrigine tablet.
Topiramate tablet.
Thyroid Conditions...................... Levothyroxine Sodium tablet.
Urologic (Bladder & Prostate) Health.... Alfuzosin HCL SA tablet.
Doxazosin Mesylate tablet.
Finasteride tablet.
Oxybutynin Chloride tablet.
Oxybutynin Chloride SA tablet.
Tamsulosin HCL capsule.
Terazosin HCL capsule.
----------------------------------------------------------------------------------------------------------------
Signing Authority
The Secretary of Veterans Affairs, or designee, approved this
document and authorized the undersigned to sign and submit the document
to the Office of the Federal Register for publication electronically as
an official document of the Department of Veterans Affairs. Gina S.
Farrisee, Deputy Chief of Staff, Department of Veterans Affairs,
approved this document on February 12, 2018, for publication.
Dated: February 12, 2018.
Jeffrey Martin,
Impact Analyst, Office of Regulation Policy & Management, Office of the
Secretary, Department of Veterans Affairs.
[FR Doc. 2018-03724 Filed 2-22-18; 8:45 am]
BILLING CODE 8320-01-P
